Disease: Ebola
- 10 years after the 2014-16 Ebola epidemic in west Africa: advances and challenges in African epidemic preparedness
- A bivalent Adenovirus-Vectored Vaccine induces a robust humoral response, but does not protect cynomolgus macaques against a lethal challenge with Sudan virus
- A Framework for Assessing the Impact of Outbreak Response Immunization Programs
- A glass-half-full perspective on negative data in Ebolavirus vaccine studies
- A novel MARV glycoprotein-specific antibody with potentials of broad-spectrum neutralization to filovirus
- A Single-shot ChAd3 Vaccine Provides Protection from Intramuscular and Aerosol Sudan Virus Exposure
- A tale of endurance: bats, viruses and immune dynamics
- Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccine regimen plus Ad26.ZEBOV booster at 1 year versus 2 years in health-care and front-line workers in the Democratic Republic of the Congo: secondary and exploratory outcomes of an open-label, randomised, ph
- An oral antiviral for Ebola disease
- Antiviral Protein-Protein Interaction Inhibitors
- Armed actor interventions in humanitarian and public health crises: examining perspectives of crisis-affected community members
- Assessment of the integrated disease surveillance and response system implementation in health zones at risk for viral hemorrhagic fever outbreaks in North Kivu, Democratic Republic of the Congo, following a major Ebola outbreak, 2021
- Bivalent VSV Vectors Mediate Rapid and Potent Protection from Andes Virus Challenge in Hamsters
- Broad antibody and T cell responses to Ebola, Sudan, and Bundibugyo ebolaviruses using mono- and multi-valent adjuvanted glycoprotein vaccines
- Chaos theory in the understanding of COVID-19 pandemic dynamics
- Childhood vision impairment and blindness in West Africa: public health measures and implications for systemic health
- Computational and experimental identification of keystone interactions in Ebola virus matrix protein VP40 dimer formation
- Computational and stability analysis of Ebola virus epidemic model with piecewise hybrid fractional operator
- Correction: Impact of Ebola and COVID-19 on maternal, neonatal, and child health care among populations affected by conflicts: a scoping review exploring demand and supply-side barriers and solutions
- Critical perspective on infodemic and infodemic management in previous Ebola outbreaks in Uganda
- Derivation and Internal Validation of a Mortality Prognostication Machine Learning Model in Ebola Virus Disease Based on Iterative Point-of-Care Biomarkers
- Design and characterization of protective pan-ebolavirus and pan-filovirus bispecific antibodies
- Detecting changes in the transmission rate of a stochastic epidemic model
- Development of a non-infectious control for viral hemorrhagic fever PCR assays
- Development of a Reliable and Valid Survey Instrument to Measure Nurses' Health Behaviors Towards an Infectious Disease
- Developments in Negative-Strand RNA Virus Reverse Genetics
- Did aid to the Ebola crisis divert aid for reproductive, maternal, and newborn health? An analysis of donor-reported data in Sierra Leone
- Disseminating information on acute public health events globally: experiences from the WHO's Disease Outbreak News
- Dopamine-Derived Guanidine Alkaloids from a Didemnidae Tunicate: Isolation, Synthesis, and Biological Activities
- Ebola lessons: Did prior epidemic experience protect against the spread of COVID-19 in Sierra Leone?
- Ebola virus disease sequelae and viral persistence in animal models: Implications for the future
- Ebola Virus Glycoprotein Strongly Binds to Membranes in the Absence of Receptor Engagement
- Ebola virus VP35 interacts non-covalently with ubiquitin chains to promote viral replication
- Ebola-specific therapeutic antibodies from lab to clinic: The example of ZMapp
- Effects of Shock and Vibration on Product Quality during Last-Mile Transportation of Ebola Vaccine under Refrigerated Conditions(1)
- Engaging the public in decisions about emergency vaccine deployment strategies: Lessons from scenario-based discussions in Sierra Leone
- Establishment and application of a surrogate model for human Ebola virus disease in BSL-2 laboratory
- Evaluating the risk of conflict on recent Ebola outbreaks in Guinea and the Democratic Republic of the Congo
- Evaluation of fendiline treatment in VP40 system with nucleation-elongation process: a computational model of Ebola virus matrix protein assembly
- Exploring equity in global health collaborations: a qualitative study of donor and recipient power dynamics in Liberia
- Factors Associated with Reliable Contact Tracing During the 2021 Ebola Virus Disease Outbreak in Guinea
- Geographic Disparities in Domestic Pig Population Exposure to Ebola Viruses, Guinea, 2017-2019
- Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of
- Global burden associated with 85 pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019
- Helminth exposure and immune response to the two-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccine regimen
- Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase 1/1b trials
- How Should Resources From National Stockpiles Be Managed?
- Identification and Potential Roles of Human MicroRNAs in Ebola Virus Infection and Disease Pathogenesis
- Impact of Recombinant VSV-HIV Prime, DNA-Boost Vaccine Candidates on Immunogenicity and Viremia on SHIV-Infected Rhesus Macaques
- Kenyan Free-Tailed Bats Demonstrate Seasonal Birth Pulse Asynchrony with Implications for Virus Maintenance
- Lest we forget: Dr Paul Farmer (1959-2022) 'A Global Health Leader at Harvard'
- Long-Term Clinical Safety of the Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: A Prospective, Multi-Country, Observational Study
- Lot-to-lot consistency, immunogenicity, and safety of the Ad26.ZEBOV, MVA-BN-Filo Ebola virus vaccine regimen: A phase 3, randomized, double-blind, placebo-controlled trial
- Mapping knowledge landscapes and emerging trends of Marburg virus: A text-mining study
- Mapping of susceptibility loci for Ebola virus pathogenesis in mice
- Methodological issues of retrospective surveys for measuring mortality of highly clustered diseases: case study of the 2014-16 Ebola outbreak in Bo District, Sierra Leone
- Minor electrostatic changes robustly increase VP40 membrane binding, assembly, and budding of Ebola virus matrix protein derived virus-like particles
- New perspective of small-molecule antiviral drugs development for RNA viruses
- Oral administration of obeldesivir protects nonhuman primates against Sudan ebolavirus
- Packaging Quantum Dots in Viral Particles via a Strep-tag II/Streptavidin System for Single-Virus Tracking
- Paediatric meningitis in the conjugate vaccine era and a novel clinical decision model to predict bacterial aetiology
- Peak transgene expression after intramuscular immunization of mice with adenovirus 26-based vector vaccines correlates with transgene-specific adaptive immune responses
- Perceptions, attitudes, and willingness of healthcare and frontline workers to participate in an Ebola vaccine trial in Uganda
- Phosphatidylserine-exposing extracellular vesicles in body fluids are an innate defence against apoptotic mimicry viral pathogens
- Plasmonic Fluorescence Sensors in Diagnosis of Infectious Diseases
- Preparing for epidemics. A strategy for strengthening social science skills in Africa
- Preservation of scRNA-Seq Libraries Using Existing Inactivation Protocols
- Probing the pH-dependency of DC-SIGN/R multivalent lectin-glycan interactions using polyvalent glycan-gold nanoparticles
- Protective Efficacy of Lyophilized Vesicular Stomatitis Virus-Based Vaccines in Animal Model
- Protocol for testing filovirus treatments during outbreaks
- Public health surveillance through community health workers: a scoping review of evidence from 25 low-income and middle-income countries
- Rapid Review of Therapy Protocols for Public Health Emergencies
- Readiness To Manage Ebola Virus Disease Among Emergency Healthcare Workers in Uganda: A Nationwide Multicenter Survey
- Recent advances in the treatment of Ebola disease: A brief overview
- Regaining the path to malaria elimination: Lessons from the pandemic
- Rhabdomyolysis, acute kidney injury, and mortality in Ebola virus disease: retrospective analysis of cases from Eastern Democratic Republic of the Congo, 2019
- Safety and Immunogenicity of Accelerated Heterologous Two-dose Ebola Vaccine Regimens in Adults With and Without HIV in Africa
- Scalable gradients enable Hamiltonian Monte Carlo sampling for phylodynamic inference under episodic birth-death-sampling models
- Single-cell image-based genetic screens systematically identify regulators of Ebola virus subcellular infection dynamics
- Sosuga Virus Detected in Egyptian Rousette Bats (<em>Rousettus aegyptiacus</em>) in Sierra Leone
- Summary of WHO infection prevention and control guideline for Ebola and Marburg disease: a call for evidence based practice
- Systematic Review of Scales for Measuring Infectious Disease-Related Stigma
- The characteristics of BCR-CDR3 repertoire in COVID-19 patients and SARS-CoV-2 vaccinated volunteers
- The Current Pathogenicity and Potential Risk Evaluation of Marburg Virus to Cause Mysterious "Disease X"-An Update on Recent Evidences
- The impact of conflict on infectious disease: a systematic literature review
- The potential risk components and prevention measures of the Ebola virus disease outbreak in Liberia: An in-depth interview with the health workers and stakeholders
- The Role of Ebola Virus VP24 Nuclear Trafficking Signals in Infectious Particle Production
- The S1 spike protein of SARS-CoV-2 upregulates the ERK/MAPK signaling pathway in DC-SIGN-expressing THP-1 cells
- The west Africa Ebola virus disease outbreak: 10 years on
- Time to care and factors influencing appropriate Sudan Virus Disease care among case patients in Uganda, September to November 2022
- Towards Resilient Healthcare Systems: A Framework for Crisis Management
- Tropical sexually transmitted infections Summary of the SFMTSI Scientific Day of November 9, 2023
- Two-way pharmacodynamic modeling of drug combinations and its application to pairs of repurposed Ebola and SARS-CoV-2 agents
- Update on known and emergent viruses affecting human male genital tract and fertility
- Use of Ebola Vaccines - Worldwide, 2021-2023
- Use of in silico approaches, synthesis and profiling of Pan-filovirus GP-1,2 preprotein specific antibodies
- Using serosurveys to optimize surveillance for zoonotic pathogens
- Using structure prediction of negative sense RNA virus nucleoproteins to assess evolutionary relationships
- Utilizing cost-effective portable equipment to enhance COVID-19 variant tracking both on-site and at a large scale
- Visual acuity and vision-related quality of life outcomes following cataract surgery in Ebola virus disease survivors